Definition:
The Cold and Cough market comprises over-the-counter natural and synthetic agents to relieve cough, expectorants and sore throat remedies, cold remedies and preparations against flu-like infections. Cough and cold medication includes medicines in the form of pills, syrups, lozenges, sprays, ointments and granulate for external and internal application. Not included are prescription medicines, preparations that are against the state law or are no explicit cold or cough drugs (e.g. painkillers). Among the top-selling medicines for cold and cough are nose sprays, Mucosolvan syrup, Grippostad C, Sinupret forte, Gelomyrtol, Dolo-Dobendan, Aspirin Complex, Bepanthen nose and eye cream, ACC Akut, Neo-Angin, Vick Vaporup, Isla Moos. It includes both products which are exclusively sold in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.
Additional Information:
The Cold and Cough market comprises revenues, average revenue per capita. Sales channels show online and offline revenue. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.
Notes: Data shown is using current exchange rates and reflects market impacts of the Russia-Ukraine war.
Most recent update: Mar 2024
Source: Statista Market Insights
Most recent update: Mar 2024
Source: Statista Market Insights
Notes: The chart “Comparable Estimates” shows the forecasted development of the selected market from different sources. Please see the additional information for methodology and publication date.
Most recent update: Mar 2024
The Cold & Cough Remedies market in Serbia has been experiencing significant growth in recent years. Customer preferences and local special circumstances have played a role in shaping the trends in this market. Additionally, underlying macroeconomic factors have also contributed to the development of the Cold & Cough Remedies market in Serbia.
Customer preferences: In Serbia, customers have shown a strong preference for over-the-counter cold and cough remedies. This is largely due to the convenience and accessibility of these products. Customers often prefer to self-medicate and treat their symptoms at home, rather than seeking medical advice. This preference for self-care has led to an increased demand for cold and cough remedies that can be easily purchased without a prescription.
Trends in the market: One of the key trends in the Cold & Cough Remedies market in Serbia is the growing demand for natural and herbal remedies. Customers are increasingly seeking products that are perceived as more natural and have fewer side effects. This trend is driven by a growing awareness of the potential risks associated with the long-term use of conventional medications. As a result, manufacturers are introducing a wider range of natural and herbal remedies to cater to this demand.Another trend in the market is the increasing popularity of combination products. These products offer multiple benefits, such as relieving congestion, cough, and sore throat, all in one formulation. Customers find these combination products convenient and cost-effective, as they can address multiple symptoms with a single purchase.
Local special circumstances: Serbia has a relatively high prevalence of cold and cough symptoms, especially during the winter months. The cold climate and close living quarters in many urban areas contribute to the spread of respiratory infections. This creates a constant demand for cold and cough remedies throughout the year. Additionally, the high level of air pollution in some cities further exacerbates respiratory symptoms, leading to an increased need for effective remedies.
Underlying macroeconomic factors: The Cold & Cough Remedies market in Serbia is also influenced by underlying macroeconomic factors. The country has experienced steady economic growth in recent years, which has increased the disposable income of consumers. As a result, customers are more willing to spend on healthcare products, including cold and cough remedies. The growing middle class in Serbia is also driving the demand for higher quality and more expensive products.In conclusion, the Cold & Cough Remedies market in Serbia is developing in response to customer preferences, local special circumstances, and underlying macroeconomic factors. The demand for over-the-counter remedies, natural and herbal products, and combination formulations is on the rise. The prevalence of cold and cough symptoms, as well as the increasing disposable income of consumers, are key drivers of this market's growth.
Most recent update: Mar 2024
Source: Statista Market Insights
Most recent update: Mar 2024
Source: Statista Market Insights
Most recent update: Mar 2024
Source: Statista Market Insights
Data coverage:
Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.Modeling approach / Market size:
Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.Notes: Based on data from IMF, World Bank, UN and Eurostat
Most recent update: Sep 2024
Source: Statista Market Insights